IV Acetaminophen for Postoperative Pain in Newborns
(IVA POP NICU Trial)
Trial Summary
What is the purpose of this trial?
The goal of this pilot randomized clinical trial is to determine the effect of the addition of IV acetaminophen to opioid-based pain regimes for infants admitted to the neonatal intensive care unit (NICU) after surgery. This is a pilot trial; the main goals are to make sure our study methods work before performing a larger study. The main clinical aims are: 1. Determine if adding IV acetaminophen reduces pain 2. Determine if adding IV acetaminophen reduces opioid use 3. Determine if adding IV acetaminophen reduces complications Participants will be randomized to two groups: Comparator: Fentanyl and IV acetaminophen Control: Fentanyl and placebo Patients will receive either IV acetaminophen or placebo at regular intervals for seven days after surgery. Patients will be followed daily during that period. Charts will be reviewed at 90-days for final outcomes.
Research Team
Mark Walton, MD
Principal Investigator
McMaster University
Eligibility Criteria
This trial is for newborns in the NICU at McMaster Children's Hospital who've had major surgery. They can join if they haven't taken acetaminophen recently, aren't in another study, and got consent from guardians. Babies with liver or kidney problems, certain blood issues, or allergies to the drugs being tested cannot participate.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Intravenous Acetaminophen (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster Children's Hospital
Lead Sponsor